Mark T. Drayson

24.0k citations
373 papers · 14.7k · 3 hit papers · h-index 63

Impact in

Papers in

    • Multiple Myeloma Research and Treatments 161
    • Protein Degradation and Inhibitors 38
    • Amyloidosis: Diagnosis, Treatment, Outcomes 23

Mark T. Drayson

361 papers receiving 14.4k citations

Mark T. Drayson's Hit Papers

First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial 2010 · 407 citations
4070+7+15Years since publication4008001.2k

Peers

Mark T. Drayson
Comparison fields: 5 of 167
  • Hematology 5.9k
  • Behavioral Neuroscience 718
  • Oncology 3.5k
  • Biological Psychiatry 315
  • Rehabilitation 819
Replace Cem Gabay with:
Cem Gabay Switzerland
William B. Ershler United States
Cornelia M. Weyand United States
Jörg J. Goronzy United States
Ronald L. Wilder United States
Frank Buttgereit Germany
Giamila Fantuzzi United States
Jürgen Schölmerich Germany
Maurizio Cutolo Italy
Irving Kushner United States
Mark T. Drayson relative to Cem Gabay Switzerland Cem Gabay's profile →
Citations per field
00.5×4.8×
Cem Gabay · 1×
Citations per year

Countries citing papers authored by Mark T. Drayson

Since Specialization
Citations

This map shows the geographic impact of Mark T. Drayson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark T. Drayson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark T. Drayson more than expected).

Fields of papers citing papers by Mark T. Drayson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark T. Drayson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark T. Drayson. The network helps show where Mark T. Drayson may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark T. Drayson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark T. Drayson Line = papers co-authored together Mark T. Drayson links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 373 papers — load more, or switch the sort, to bring in the rest.

#Work
1
High-Dose Chemotherapy with Hematopoietic Stem-Cell Rescue for Multiple Myeloma
Hit paper breakdown →
20031348
2
Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD4+ regulatory T‐cell subset
Hit paper breakdown →
2004618
3 2001454
4
First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial
Hit paper breakdown →
2010407
5 2005351
6 2005334
7 2013287
8 2001264
9 1998240
10 2011235
11 2013215
12 2016194
13 2003191
14 2008186
15 2009160
16 1987149
17 2003144
18 2011141
19 2008141
20 2011140

About Mark T. Drayson

Mark T. Drayson is a scholar working on Hematology, Molecular Biology, Oncology, Immunology and Genetics, having authored 373 papers that have together received 14.7k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (161 papers), Cancer Treatment and Pharmacology (40 papers), Protein Degradation and Inhibitors (38 papers), Exercise and Physiological Responses (28 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (23 papers), Stress Responses and Cortisol (22 papers), Peptidase Inhibition and Analysis (22 papers) and Monoclonal and Polyclonal Antibodies Research (19 papers). The work is most often cited by research in Hematology (5.9k citations), Behavioral Neuroscience (718 citations), Oncology (3.5k citations), Biological Psychiatry (315 citations) and Rehabilitation (819 citations). Mark T. Drayson has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Gareth J. Morgan, Faith E. Davies, Roger G. Owen, Douglas Carroll, J. A. Child, Christopher Ring, Victoria E. Burns, A.R. Bradwell, Hugh D Carr-Smith and Julia Brown. Their work appears in journals such as Blood, British Journal of Haematology, Brain Behavior and Immunity, Psychophysiology and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact